Aberrant phosphorylation inactivates Numb in breast cancer causing expansion of the stem cell pool

Maria Grazia Filippone1, Stefano Freddi1, Silvia Zecchini1

  • 1IEO-IRCCS, Istituto Europeo di Oncologia-Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy.

Insights

Asymmetric cell division relies on Numb protein partitioning and differential phosphorylation for mammary stem cell regulation. Aberrant Numb phosphorylation in cancer drives uncontrolled stem cell expansion and aggressive disease.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Stem Cell Biology

Background:

  • Asymmetric cell division is crucial for preventing stem cell (SC) overexpansion.
  • Numb protein plays a key role in directing daughter cell fates during SC division.

Purpose of the Study:

  • To investigate the role of Numb partitioning and phosphorylation in mammary stem cell (SC) dynamics.
  • To elucidate the mechanism of Numb regulation by protein kinase C (PKC) isoforms.
  • To understand how this mechanism is altered in breast cancer.

Main Methods:

  • Studied asymmetric Numb partitioning during mammary stem cell mitosis.
  • Investigated the role of differential Numb phosphorylation in daughter cell fate determination.
  • Analyzed the involvement of atypical PKCζ in Numb inactivation.
  • Examined aberrant PKC activation in breast cancer stem cells.

Main Results:

  • Asymmetric Numb partitioning alone is insufficient for controlling mammary SC dynamics.
  • Differential phosphorylation and functional inactivation of Numb are essential.
  • Atypical PKCζ mediates asymmetric Numb phosphorylation/inactivation in progenitor cells.
  • Aberrant PKC activation in breast cancer leads to symmetric division and cancer SC expansion.

Conclusions:

  • Proper mammary SC regulation requires both asymmetric Numb partitioning and differential phosphorylation.
  • PKC-mediated Numb phosphorylation is a critical control point.
  • Subversion of this mechanism by aberrant PKCs contributes to breast cancer progression.
  • Targeting Numb phosphorylation offers a potential therapeutic strategy for breast cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.6K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.9K